Amiet, Ralph D.

Andrew M. Alul is an associate with Rakoczy Molino Mazzochi Siwik LLP. His practice focuses primarily on intellectual property litigation and counseling, particularly pharmaceutical drug patent litigation and regulatory litigation involving the U.S. Food and Drug Administration (FDA).

Litigation

Mr. Alul’s experience includes litigation and alternative dispute resolution involving chemical, pharmaceutical, mechanical, and software patents and licenses on patented technology. Specifically, Mr. Alul has been involved in representing plaintiffs and defendants in disputes involving patents directed to pharmaceutical drugs, web browser and operating system software, radiographic film, and electrophoresis separation technology.

Mr. Alul experience also includes litigation brought under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act for pharmaceutical products, and under the Administrative Procedures Act. Mr. Alul has participated in litigation involving such drugs as Femara (letrozole), Levoxyl (levothyroxine), Plavix (clopidogrel bisulfate), Plendil (felodipine), and Zithromax (azithromycin).

Legal Due Diligence and Opinion Work

Mr. Alul has prepared opinions of counsel for clients on a variety of intellectual property issues, including patent infringement clearance/right to use opinions on scores of pharmaceutical drugs, validity opinions on patents covering pharmaceutical drugs and inkjet printing devices, and legal opinions on other various subject matter, including the scope of rights acquired under patent term extensions granted under 35 U.S.C. 156, the validity of certain 156 extensions, and various trade secret matters. Mr. Alul has also carried out due diligence investigations involving patent portfolios for pharmaceutical drugs and drug delivery technology.

Patent Prosecution

Mr. Alul has had experience prosecuting patent applications, including applications involving bone putty and bone matrix grafting material, cartilage regeneration compositions, and sieving matrices used in electrophoresis separation and detection systems. Mr. Alul has also prepared appeal briefs to the Board of Patent Appeals and Interferences for the USPTO appealing final claim rejections in various patent prosecutions, including the prosecution of an application dealing with novel polymer-based porous cellular foams used in wound dressing.

Previous Experience

Prior to joining Rakoczy Molino Mazzochi Siwik LLP, Mr. Alul was an associate at Schiff Hardin LLP.